1 / 5

Long-term treatment adherence is high in patients with systolic heart failure

Patient adherence to evidence-based pharmacotherapy and use of β -blockers in systolic heart failure patients. Long-term treatment adherence is high in patients with systolic heart failure. N=8792 patients.

oleg
Download Presentation

Long-term treatment adherence is high in patients with systolic heart failure

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Patient adherence to evidence-based pharmacotherapy and use of β-blockers in systolic heart failure patients

  2. Long-term treatment adherence is high in patients with systolic heart failure N=8792 patients Data from 8792 patients with systolic heart failure attending heart failure clinics (HFCs) in Denmark from 2002 to 2009. GP, general practitioners; RAS, renin-angiotensin system. Gjesing A et al. Eur J Heart Fail. 2013 Feb 8. Epub ahead of print. doi:10.1093/eurjhf/hft011

  3. In practice, mean β-blocker doses are lower than target doses recommended in the guidelines N=8792 patients *Mean dose **Doses recommended in guidelines and used in major clinical trials Data from 8792 patients with systolic heart failure attending heart failure clinics (HFCs) in Denmark from 2002 to 2009 Gjesing A et al. Eur J Heart Fail. 2013 Feb 8. Epub ahead of print. doi:10.1093/eurjhf/hft011

  4. After 6 months, thereiseither no or limitedβ-blocker uptitration N=8792 patients % of target dose recommended by guidelines Data from 8792 patients with systolic heart failure attending heart failure clinics (HFCs) in Denmark from 2002 to 2009. Gjesing A et al. Eur J Heart Fail. 2013 Feb 8. Epub ahead of print. doi:10.1093/eurjhf/hft011

  5. Take-home messages: • Long-term adherence to treatment is high in patients with systolic heart failure. • In practice, mean β-blocker doses are lower than target doses recommended in the guidelines. • In practice, after 6 months, there is either no or limited β-blocker uptitration.

More Related